We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

195 hedge funds and large institutions have $1.51B invested in Olema Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more call options, than puts

Call options by funds: $41.3M | Put options by funds: $11.1M

43% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 51

8% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 50

3% less funds holding

Funds holding: 200 → 195 (-5)

15.73% less ownership

Funds ownership: 132.15% → 116.42% (-16%)

33% less capital invested

Capital invested by funds: $2.27B → $1.51B (-$755M)

73% less funds holding in top 10

Funds holding in top 10: 11 → 3 (-8)

Holders
195
Holders Change
-5
Holders Change %
-2.5%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-72.73%
% of All Funds
0.04%
New
46
Increased
73
Reduced
51
Closed
50
Calls
$41.3M
Puts
$11.1M
Net Calls
+$30.2M
Net Calls Change
+$16.9M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$119M
2
State Street
State Street
Massachusetts
+$45.7M
3
SL
Siren LLC
Connecticut
+$32.4M
4
CAM
Cormorant Asset Management
Massachusetts
+$25.6M
5
DFO
Duquesne Family Office
New York
+$22M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$28M
2
VPC
Vestal Point Capital
New York
-$27.2M
3
SC
Samlyn Capital
New York
-$26.7M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$23M
5
EAM
Eventide Asset Management
Massachusetts
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
QCM
76
Quantinno Capital Management
New York
$1.42M +$758K +34,030 +56%
YIH
77
Y-Intercept (HK)
Hong Kong
$1.35M +$1.18M +53,176 +143%
Balyasny Asset Management
78
Balyasny Asset Management
Illinois
$1.34M -$1.73M -77,637 -46%
AQR Capital Management
79
AQR Capital Management
Connecticut
$1.34M +$187K +8,395 +10%
TI
80
Tidal Investments
Wisconsin
$1.27M +$1.9M +85,151 New
RhumbLine Advisers
81
RhumbLine Advisers
Massachusetts
$1.26M +$222K +9,971 +13%
American Century Companies
82
American Century Companies
Missouri
$1.22M -$271K -12,166 -13%
TE
83
Tema ETFs
New York
$1.18M +$773K +34,738 +78%
Swiss National Bank
84
Swiss National Bank
Switzerland
$1.11M +$1.66M +74,600 New
State of Wisconsin Investment Board
85
State of Wisconsin Investment Board
Wisconsin
$1.08M +$841K +37,763 +108%
Creative Planning
86
Creative Planning
Kansas
$1.08M +$169K +7,580 +12%
Point72 Asset Management
87
Point72 Asset Management
Connecticut
$1.06M -$5.27M -236,783 -77%
Connor, Clark & Lunn Investment Management (CC&L)
88
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.05M +$1.57M +70,711 New
EGM
89
Engineers Gate Manager
New York
$1.05M +$985K +44,264 +169%
AA
90
ALPS Advisors
Colorado
$955K -$12.4K -557 -0.9%
HT
91
Headlands Technologies
Illinois
$885K +$1.32M +59,374 New
PA
92
Profund Advisors
Maryland
$873K +$917K +41,196 +237%
LPL Financial
93
LPL Financial
California
$856K +$26.9K +1,210 +2%
Ameriprise
94
Ameriprise
Minnesota
$855K -$3.28M -147,267 -72%
Swedbank
95
Swedbank
Sweden
$822K – – –
NAMI
96
Nomura Asset Management International
Pennsylvania
$746K – – –
PIC
97
Portland Investment Counsel
Ontario, Canada
$746K – – –
Massachusetts Financial Services
98
Massachusetts Financial Services
Massachusetts
$701K +$1.05M +47,012 New
Wells Fargo
99
Wells Fargo
California
$692K -$839K -37,697 -45%
Nomura Holdings
100
Nomura Holdings
Japan
$626K +$934K +41,960 New
2 3
4
5 6

OLMA Hedge Fund Activity: Q1 2026 in Review

195 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2026, worth a combined $1.51B — down 33% from $2.27B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of OLMA and 46 opened new positions — a net loss of 4 holders — while 51 trimmed existing stakes and 73 added.

The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Franklin Resources, cutting an estimated $28M.

  • 195 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2026, down from 200 in Q4 2025.
  • Funds reported $1.51B of Olema Pharmaceuticals stock for Q1 2026, down 33% quarter-over-quarter.
  • 46 funds opened new Olema Pharmaceuticals positions in Q1 2026 and 50 closed out, a net change of -4 holders.
  • The largest Olema Pharmaceuticals buyer in Q1 2026 was Fidelity Investments, an estimated $119M added.
  • The largest Olema Pharmaceuticals seller in Q1 2026 was Franklin Resources, an estimated $28M sold.

Based on aggregated 13F filings for Q1 2026.